Jennison Associates LLC Takes Position in Integer Holdings Corporation $ITGR

Key Points

• Jennison Associates LLC acquired a new stake of 13,208 shares in Integer (NYSE:ITGR) during Q4, valued at roughly $1.04 million, joining other large institutional buyers in a stock that is ~99.29% institutionally owned.
• Integer reported Q1 EPS of $1.20 (missed by $0.01) with revenue of $439.6M (a beat), and set FY2026 guidance of $5.83–$6.40, slightly below street expectations and raising near‑term execution concerns.
• The board launched a strategic review (including potential sale or combination) and analyst responses are mixed — Piper Sandler raised its target to $97 while the consensus rating is a "Hold" with a $98.29 target.

Jennison Associates LLC acquired a new stake in Integer Holdings Corporation (NYSE:ITGR - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 13,208 shares of the medical equipment provider's stock, valued at approximately $1,036,000.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. William Blair Investment Management LLC acquired a new position in Integer during the third quarter valued at approximately $28,459,000. Public Sector Pension Investment Board raised its position in shares of Integer by 14.9% in the third quarter. Public Sector Pension Investment Board now owns 136,632 shares of the medical equipment provider's stock valued at $14,118,000 after purchasing an additional 17,699 shares during the period. Magnetar Financial LLC acquired a new stake in shares of Integer in the third quarter worth $1,890,000. New York State Common Retirement Fund boosted its holdings in shares of Integer by 12.0% during the 3rd quarter. New York State Common Retirement Fund now owns 267,613 shares of the medical equipment provider's stock worth $27,652,000 after buying an additional 28,650 shares during the period. Finally, Massachusetts Financial Services Co. MA bought a new stake in shares of Integer during the 3rd quarter worth $41,938,000. 99.29% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Integer

In other news, VP Tommy P. Thomas sold 825 shares of the stock in a transaction on Friday, March 13th. The shares were sold at an average price of $85.00, for a total value of $70,125.00. Following the completion of the transaction, the vice president owned 4,381 shares in the company, valued at approximately $372,385. This represents a 15.85% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. 1.10% of the stock is owned by company insiders.

Integer Price Performance

Shares of ITGR stock opened at $83.69 on Monday. Integer Holdings Corporation has a 12 month low of $62.00 and a 12 month high of $126.86. The company has a market capitalization of $2.85 billion, a P/E ratio of 20.87, a P/E/G ratio of 1.47 and a beta of 0.67. The stock has a 50 day moving average of $86.07 and a two-hundred day moving average of $81.46. The company has a current ratio of 3.75, a quick ratio of 2.38 and a debt-to-equity ratio of 0.77.

Integer (NYSE:ITGR - Get Free Report) last released its quarterly earnings data on Thursday, April 30th. The medical equipment provider reported $1.20 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.21 by ($0.01). The firm had revenue of $439.58 million for the quarter, compared to the consensus estimate of $426.48 million. Integer had a net margin of 7.64% and a return on equity of 12.83%. The business's revenue for the quarter was up .5% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.31 earnings per share. Integer has set its FY 2026 guidance at 5.830-6.400 EPS. As a group, equities analysts expect that Integer Holdings Corporation will post 6.4 EPS for the current year.

Analyst Ratings Changes

Several brokerages recently commented on ITGR. Raymond James Financial reiterated an "outperform" rating and issued a $101.00 target price on shares of Integer in a report on Monday, February 23rd. Citigroup decreased their price target on shares of Integer from $92.00 to $89.00 and set a "neutral" rating for the company in a report on Friday. Piper Sandler reaffirmed an "overweight" rating and issued a $97.00 price target (up from $87.00) on shares of Integer in a research report on Friday. Truist Financial lifted their price objective on Integer from $95.00 to $97.00 and gave the stock a "buy" rating in a research note on Friday, February 20th. Finally, Wall Street Zen cut Integer from a "buy" rating to a "hold" rating in a research report on Sunday, January 25th. Four research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company's stock. Based on data from MarketBeat.com, Integer has a consensus rating of "Hold" and a consensus target price of $98.29.

More Integer News

Here are the key news stories impacting Integer this week:

• Positive Sentiment: Piper Sandler reaffirmed an "overweight" rating and raised its price target to $97, signaling upside potential and institutional confidence in Integer's longer‑term prospects. Piper Sandler Rating
• Positive Sentiment: Integer's board initiated a strategic review (including potential sale, merger or other combinations) to maximize shareholder value — a catalyst that can unlock premium bids or strategic alternatives over time. Integer Strategic Review
• Positive Sentiment: Market commentary highlighted that revenue beat and strength across key product lines drove a positive market reaction despite an EPS miss, supporting confidence in top-line momentum. Zacks Coverage
• Neutral Sentiment: Several analysts updated forecasts after the Q1 release; revisions are mixed and reflect differing views on margin recovery and the impact of the strategic review. Analyst Revisions
• Neutral Sentiment: Trading in ITGR was briefly halted as news was released, which can increase intraday volatility but does not change fundamentals. Q1 Results Release
• Negative Sentiment: Q1 EPS was $1.20, missing consensus by $0.01 and down from $1.31 a year ago; management set FY26 EPS guidance of $5.83–$6.40, below the street consensus (~$6.49), which raises near‑term execution concerns. Earnings Details
• Negative Sentiment: Citigroup trimmed its price target from $92 to $89 and moved to a "neutral" rating, reflecting more cautious near‑term sentiment and limiting upside from that broker's client base. Citigroup Note

About Integer

Integer Holdings Corporation NYSE: ITGR is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer's product portfolio is organized into two core segments: Advanced Delivery and MedTech.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.